1992 Winner: Outstanding Commercial Achievement in Alberta Science and Technology (Sales less than 25 million)
Company Specializes In Distinct Cancer Research
Biomira’s commitment to diagnostic and treatment capability for cancer makes the in the field of medical research. Biomira specializes in three basic areas of cancer research: invitro diagnostic kits, radio imaging and therapy, and Active Specific Immunotherapy (ASI).’
Biomira combines immunology carbohydrate chemistry to differentiate malignant tumours from healthy cells. The company is using this technology to design diagnostics and therapeutics for 90 per cent of all solid tumour cancers.
In 1987, Biomira became one of the first biotechnology companies to be listed on the Toronto Stock Exchange. The company later raised $54.4 million in 1991 through a cross-border, public share offering. The Edmonton-based company expects to increase its employment from 144 to 200 by the end of 1992.
